Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients.

Barbano R, Pasculli B, Rendina M, Fontana A, Fusilli C, Copetti M, Castellana S, Valori VM, Morritti M, Graziano P, Luigi C, Coco M, Picardo F, Mazza T, Evron E, Murgo R, Maiello E, Esteller M, Fazio VM, Parrella P.

Sci Rep. 2017 Mar 27;7:45283. doi: 10.1038/srep45283.


The Post-Surgical Long-Term Behaviour of Lung Carcinoid Tumours.

Tancredi A, Muscarella LA, la Torre A, Scaramuzzi R, Valori VM, Fazio VM, Scaramuzzi G.

Indian J Surg. 2015 Dec;77(6):481-5. doi: 10.1007/s12262-015-1290-z. Epub 2015 May 31.


Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.

Barbano R, Pasculli B, Coco M, Fontana A, Copetti M, Rendina M, Valori VM, Graziano P, Maiello E, Fazio VM, Parrella P.

Sci Rep. 2015 Dec 22;5:18592. doi: 10.1038/srep18592.


A miRNA signature for defining aggressive phenotype and prognosis in gliomas.

Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P.

PLoS One. 2014 Oct 3;9(10):e108950. doi: 10.1371/journal.pone.0108950. eCollection 2014.


Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

Parrella P, Barbano R, Pasculli B, Fontana A, Copetti M, Valori VM, Poeta ML, Perrone G, Righi D, Castelvetere M, Coco M, Balsamo T, Morritti M, Pellegrini F, Onetti-Muda A, Maiello E, Murgo R, Fazio VM.

Mol Cancer. 2014 Jun 4;13:142. doi: 10.1186/1476-4598-13-142.


Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.

Barbano R, Muscarella LA, Pasculli B, Valori VM, Fontana A, Coco M, la Torre A, Balsamo T, Poeta ML, Marangi GF, Maiello E, Castelvetere M, Pellegrini F, Murgo R, Fazio VM, Parrella P.

Epigenetics. 2013 Jan;8(1):105-12. doi: 10.4161/epi.23319. Epub 2012 Dec 18.


Aberrant genes promoter methylation in neural crest-derived tumors.

la Torre A, Muscarella LA, Parrella P, Balsamo T, Bisceglia M, Valori VM, la Torre A, Barbano R, Perrella E, Poeta ML, Melchionda G, Merla G, Maiello E, Pellicano R, Fazio VM.

Int J Biol Markers. 2012 Dec 27;27(4):e389-94. doi: 10.5301/JBM.2012.9766.


Ethical issues on defibrillator deactivation in end-of-life patients.

Facciorusso A, Stanislao M, Fanelli M, Valori VM, Valle G.

J Cardiovasc Med (Hagerstown). 2011 Jul;12(7):498-500. doi: 10.2459/JCM.0b013e3283483724. No abstract available.


Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer.

Muscarella LA, Parrella P, D'Alessandro V, la Torre A, Barbano R, Fontana A, Tancredi A, Guarnieri V, Balsamo T, Coco M, Copetti M, Pellegrini F, De Bonis P, Bisceglia M, Scaramuzzi G, Maiello E, Valori VM, Merla G, Vendemiale G, Fazio VM.

Epigenetics. 2011 Jun;6(6):710-9. Epub 2011 Jun 1.


Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.

Muscarella LA, Barbano R, D'Angelo V, Copetti M, Coco M, Balsamo T, la Torre A, Notarangelo A, Troiano M, Parisi S, Icolaro N, Catapano D, Valori VM, Pellegrini F, Merla G, Carella M, Fazio VM, Parrella P.

Epigenetics. 2011 Mar;6(3):317-25. Epub 2011 Mar 1.


High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.

Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P.

Int J Cancer. 2011 Aug 1;129(3):536-45. doi: 10.1002/ijc.25736. Epub 2010 Dec 9.


Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, Rossiello R, Zito F, Stefania T, Paradiso A, Carella M, Dallapiccola B, Murgo R, Carosi I, Bisceglia M, Fazio VM, Sidransky D, Parrella P.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2694-700. doi: 10.1158/1055-9965.EPI-08-0821. Epub 2009 Sep 29.


High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas.

Parrella P, la Torre A, Copetti M, Valori VM, Barbano R, Notarangelo A, Bisceglia M, Gallo AP, Balsamo T, Poeta ML, Carella M, Catapano D, Parisi S, Dallapiccola B, Maiello E, D'Angelo V, Fazio VM.

J Biomed Biotechnol. 2009;2009:531692. doi: 10.1155/2009/531692. Epub 2009 Jun 1.


Comparison between real-time quantitative PCR detection of HER2 mRNA copy number in peripheral blood and ELISA of serum HER2 protein for determining HER2 status in breast cancer patients.

Savino M, Parrella P, Copetti M, Barbano R, Murgo R, Fazio VM, Valori VM, Carella M, Garrubba M, Santini SA.

Cell Oncol. 2009;31(3):203-11. doi: 10.3233/CLO-2009-0468.


Cetuximab in squamous cell head and neck carcinomas.

Gebbia V, Giuliani F, Valori VM, Agueli R, Colucci G, Maiello E.

Ann Oncol. 2007 Jun;18 Suppl 6:vi5-7. Review.


Development of real-time quantitative reverse transcription-PCR for Her2 detection in peripheral blood from patients with breast cancer.

Savino M, Garrubba M, Parrella P, Baorda F, Copetti M, Murgo R, Zelante L, Carella M, Valori VM, Santini SA.

Clin Chim Acta. 2007 Sep;384(1-2):52-6. Epub 2007 Jun 6.


Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma.

Scintu M, Vitale R, Prencipe M, Gallo AP, Bonghi L, Valori VM, Maiello E, Rinaldi M, Signori E, Rabitti C, Carella M, Dallapiccola B, Altomare V, Fazio VM, Parrella P.

Cancer Lett. 2007 Sep 8;254(2):298-307. Epub 2007 May 10.


HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.

Parrella P, Scintu M, Prencipe M, Poeta ML, Gallo AP, Rabitti C, Rinaldi M, Tommasi S, Paradiso A, Schittulli F, Valori VM, Toma S, Altomare V, Fazio VM.

Cancer Lett. 2005 May 10;222(1):75-81.


Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.

Fiorentini G, Poddie DB, Cantore M, Rossi S, Tumolo S, Dentico P, Bernardeschi P, Guadagni S, Rossi G, Valori VM, De Simone M.

J Chemother. 2004 Nov;16 Suppl 5:51-4.


Acute myeloid leukemia: correlation between FAB classification criteria and surface antigenic markers.

Cascavilla N, Greco MM, Ladogana S, La Sala A, Melillo L, Musto P, Nobile M, Piano A, Valori VM, Carotenuto M.

Haematologica. 1988 Jan-Feb;73(1):37-42. No abstract available.


[Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].

Cascavilla N, Martini E, Melillo L, Musto P, Nobile M, Valori VM, Di Giorgio G, Carotenuto M.

Recenti Prog Med. 1987 Mar;78(3):108-12. Italian. No abstract available.


[Meningeal involvement in a case of B lymphocyte chronic lymphatic leukemia].

Carotenuto M, Cascavilla N, Ladogana S, Valori VM.

Haematologica. 1984 Nov-Dec;69(6):701-6. Italian. No abstract available.


Molecular heterogeneity of inherited antithrombin III deficiency.

Leone G, Valori VM, Cotumaccio R.

N Engl J Med. 1983 Oct 27;309(17):1063-5. No abstract available.


Human antithrombin III heterogeneity: a study by isoelectrofocusing and crossed immunoelectrofocusing.

Leone G, Valori VM, Cotumaccio R, Massi G.

Haemostasis. 1983;13(6):369-73.


Platelet activation and thromboembolism in patients with mitral valve prolapse.

Leone G, Valori VM, Sandric S, Cudillo L, Bizzi B.

Thromb Res. 1982 Dec 15;28(6):831-5. No abstract available.


Factor VIII complex in myelomatosis and related disorders.

Leone G, Valori VM, Zini G, Bavaro P, Bartoloni C, Bizzi B.

Ric Clin Lab. 1982 Oct-Dec;12(4):581-8.


A comparative study on the effect of dilazep and dipyridamole on some platelet functions.

Valori VM, Leone G, Traisci G, Bizzi B.

Arzneimittelforschung. 1982;32(4):403-5.


Heparin-urokinase treatment in aseptic dural sinus thrombosis.

Di Rocco C, Iannelli A, Leone G, Moschini M, Valori VM.

Arch Neurol. 1981 Jul;38(7):431-5.


Inferior vena cava thrombosis in a child with familial antithrombin III deficiency.

Leone G, Valori VM, Storti S, Myers TJ.

Thromb Haemost. 1980 Feb 29;43(1):74. No abstract available.


Supplemental Content

Loading ...
Support Center